Risk of skin cancer after neonatal phototherapy: Retrospective cohort study

Archives of Disease in Childhood

Volumn 95, Issue 10, 2010, Pages 826-831

  Brewster, David H ^a,b   Tucker, Janet S ^c   Fleming, Michael ^a   Morris, Carole ^a   Stockton, Diane L ^a   Lloyd, David J ^d   Bhattacharya, Sohinee ^c   Chalmers, James W T ^a,b  

^a INFORMATION SERVICES DIVISION   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d ABERDEEN MATERNITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; COHORT ANALYSIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEWBORN JAUNDICE; PHOTOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SKIN CANCER; SOCIAL STATUS; UNITED KINGDOM;

ADULT; BIRTH WEIGHT; EPIDEMIOLOGIC METHODS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; MALE; MELANOMA; PHOTOTHERAPY; RADIATION INJURIES; SCOTLAND; SKIN NEOPLASMS; SOCIAL CLASS; YOUNG ADULT;

EID: 77957367391     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.179275     Document Type: Article

References (42)

1. MacKie RM, Bray C, Vestey J, et al. Melanoma incidence and mortality in Scotland 1979-2003. Br J Cancer 2007;96:1772-7.
2. Brewster DH, Bhatti LA, Inglis JH, et al. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol 2007;156:1295-300.
3. Campbell J, Wallace WHB, Bhatti LA, et al. Childhood cancer in Scotland: trends in incidence, mortality, and survival, 1975-1999. Edinburgh: Information & Statistics Division, 2004.
4. http://www.isdscotland.org/cancer (Accessed 25 March 2010).
5. International Agency for Research on Cancer. Solar and ultraviolet radiation. IARC monographs on the evaluation of carcinogenic risks to humans, Vol 55. Lyon: International Agency for Research on Cancer, 1992:217-28.
6. Wang SQ, Setlow R, Berwick M, et al. Ultraviolet A and melanoma: a review. J Am Acad Dermatol 2001;44:837-46.
7. International Agency for Research on Cancer Working Group. Artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 2007;120:1116-22.
8. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001;12:69-82.
9. Bauer J, Büttner P, Luther H, et al. Blue light phototherapy of neonatal jaundice does not increase the risk for melanocytic nevus development. Arch Dermatol 2004;140:493-4.
10. Matichard E, Le Hénanff A, Sanders A, et al. Effect of neonatal phototherapy on melanocytic nevus count in children. Arch Dermatol 2006;142:1599-604.
11. Csoma Z, Hencz P, Orvos H, et al. Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 2007;119:1036-7; author reply 1037-8.
12. Csoma Z, Hencz P, Orvos H, et al. Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development. Pediatrics 2007;119:1269. (Pubitemid 46871316)
13. Csoma Z, Kemeny L, Olah J. Phototherapy for neonatal jaundice. N Engl J Med 2008;358:2523-4; author reply 2524-5.
14. Mahé E, Beauchet A, Aegerter P, et al. Neonatal blue-light phototherapy does not increase nevus count in 9-year-old children. Pediatrics 2009;123:e896-900.
15. Berg P, Lindelöf B. Is phototherapy in neonates a risk factor for malignant melanoma development? Arch Pediatr Adolesc Med 1997;151:1185-7.
16. Ip S, Chung M, Kulig J, et al.; American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004;114:e130-53.
17. McDonagh AF. Phototherapy: from ancient Egypt to the new millennium. J Perinatol 2001;21(Suppl 1):S7-12.
18. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008;358:920-8.
19. http://www.abdn.ac.uk/amnd/ (Accessed 25 March 2010).
20. Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003;326:845-51.
21. Faggiano F, Partanen T, Kogevinas M, et al. Socioeconomic differences in cancer incidence and mortality. IARC Sci Publ 1997;138:65-176.
22. Morris R, Carstairs V. Which deprivation? A comparison of selected deprivation indexes. J Public Health Med 1991;13:318-26.
23. Kendrick S, Clarke J. The Scottish Record Linkage System. Health Bull (Edinb) 1993;51:72-9.
24. Kendrick S. The development of record linkage in Scotland: the responsive application of probability matching. In: Committee on Applied and Theoretical Statistics, National Research Council; Federal Committee on Statistical Methodology, Office of Management and Budget. Record linkage techniques - 1997: proceedings of an International Workshop and Exposition. Washington DC, USA: National Academies Press, 1999:319-32. http://www.nap.edu/catalog.php?record - id=6491 (Accessed 25 March 2010).
25. Liddell FD. Simple exact analysis of the standardised mortality ratio. J Epidemiol Community Health 1984;38:85-8.
26. Silcocks P. Estimating confidence limits on a standardised mortality ratio when the expected number is not error free. J Epidemiol Community Health 1994;48:313-17.
27. Melia J, Frost T, Graham-Brown R, et al. Problems with registration of cutaneous malignant melanoma in England. Br J Cancer 1995;72:224-8.
28. Leman JA, Evans A, Mooi W, et al. Outcomes and pathological review of a cohort of children with melanoma. Br J Dermatol 2005;152:1321-3.
29. Maisels JM, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008;358:2524-5; author reply.
30. Godley BF, Shamsi FA, Liang FQ, et al. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J Biol Chem 2005;280:21061-6.
31. Omata Y, Lewis JB, Rotenberg S, et al. Intra- and extracellular reactive oxygen species generated by blue light. J Biomed Mater Res A 2006;77:470-7.
32. Botta C, Di Giorgio C, Sabatier AS, et al. Genotoxicity of visible light (400-800 nm) and photoprotection assessment of ectoin, L-ergothioneine and mannitol and four sunscreens. J Photochem Photobiol B, Biol 2008;91:24-34.
33. Rosenstein BS, Ducore JM. Enhancement by bilirubin of DNA damage induced in human cells exposed to phototherapy light. Pediatr Res 1984;18:3-6.
34. Sideris EG, Papageorgiou GC, Charalampous SC, et al. A spectrum response study on single strand DNA breaks, sister chromatid exchanges, and lethality induced by phototherapy lights. Pediatr Res 1981;15:1019-23.
35. Okuno T, Saito H, Ojima J. Evaluation of blue-light hazards from various light sources. Dev Ophthalmol 2002;35:104-12.
36. Fernandes BF, Marshall JC, Burnier MN Jr. Blue light exposure and uveal melanoma. Ophthalmology 2006;113:1062.e1; author reply 1062.
37. Shah CP, Weis E, Lajous M, et al. Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis. Ophthalmology 2005;112:1599-607.
38. Setlow RB. Spectral regions contributing to melanoma: a personal view. J Investig Dermatol Symp Proc 1999;4:46-9.
39. Marshall JC, Gordon KD, McCauley CS, et al. The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines. Melanoma Res 2006;16:537-41.
40. Di Cesare S, Maloney S, Fernandes BF, et al. The effect of blue light exposure in an ocular melanoma animal model. J Exp Clin Cancer Res 2009;28:48.
41. Ohara M, Kawashima Y, Katoh O, et al. Blue light inhibits the growth of B16 melanoma cells. Jpn J Cancer Res 2002;93:551-8.
42. Manning WS Jr, Greenlee PG, Norton JN. Ocular melanoma in a Long Evans rat. Contemp Top Lab Anim Sci 2004;43:44-6.